These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 1675602)

  • 1. [Ulcer prevention in therapy with low-dose acetylsalicylic acid?].
    Koop H
    Dtsch Med Wochenschr; 1991 Jun; 116(25):996-7. PubMed ID: 1675602
    [No Abstract]   [Full Text] [Related]  

  • 2. [What is the role of H2 receptor blockers today in ulcer therapy?].
    Creutzfeldt W
    Internist (Berl); 1996 Sep; 37(9):937-8. PubMed ID: 8964690
    [No Abstract]   [Full Text] [Related]  

  • 3. Prevention of peptic ulceration in patients receiving NSAIDs.
    Ballinger A
    Br J Hosp Med; 1993 Jun 2-15; 49(11):767-72. PubMed ID: 8101464
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Helicobacter pylori infection and the risk of gastro-duodenal damage in symptomatic elderly chronic low-dose aspirin users: effect of antisecretory drugs.
    Pilotto A; Franceschi M; Leandro G; Longo MG; Perri F; Scarcelli C
    Age Ageing; 2004 Jul; 33(4):402-4. PubMed ID: 15226108
    [No Abstract]   [Full Text] [Related]  

  • 5. Steroid therapy and H2-receptor antagonists: pharmacoeconomic implications.
    Marcus P; McCauley DL
    Clin Pharmacol Ther; 1997 May; 61(5):503-8. PubMed ID: 9164412
    [No Abstract]   [Full Text] [Related]  

  • 6. Prevention of NSAID-induced GI mucosal injury.
    Gerritz S; Newton WP
    J Fam Pract; 1997 Feb; 44(2):130-1. PubMed ID: 9040509
    [No Abstract]   [Full Text] [Related]  

  • 7. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and treatment of ulcers induced by nonsteroidal anti-inflammatory drugs: an update.
    Dajani EZ; Agrawal NM
    J Physiol Pharmacol; 1995 Mar; 46(1):3-16. PubMed ID: 7599335
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Coronary heart disease patient does not tolerate acetylsalicylic acid. Can clopidogrel be prescribed?].
    Rupprecht HJ
    MMW Fortschr Med; 2007 Apr; 149(14):19. PubMed ID: 17668757
    [No Abstract]   [Full Text] [Related]  

  • 10. [Prevention and treatment of low-dose aspirin induced gastric ulcer in coronary artery disease after coronary intervention].
    Yokoi H
    Nihon Rinsho; 2011 Jun; 69(6):1061-6. PubMed ID: 21688628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Secondary and primary prophylaxis of gastropathy associated with nonsteroidal antiinflammatory drugs or low-dose-aspirin: a review based on four clinical scenarios].
    Limmer S; Ittel TH; Wietholtz H
    Z Gastroenterol; 2003 Aug; 41(8):719-28. PubMed ID: 12910426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Current aspects of the therapy of gastroduodenal peptic ulcer].
    Castro Lde P
    Rev Hosp Clin Fac Med Sao Paulo; 1983; 38(2):90-102. PubMed ID: 6139870
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antirheumatic drug-induced damage of the gastroduodenal mucosa: approach to prevention].
    Domschke S; Domschke W
    Internist (Berl); 1986 Oct; 27(10):630-6. PubMed ID: 2878905
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of nonsteroidal anti-inflammatory drug-induced gastropathy.
    Scheiman JM
    Am J Manag Care; 2001 Feb; 7(1 Suppl):S10-4. PubMed ID: 11225347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Gastrointestinal bleeding during low dose acetylsalicylic acid. Is Godamed-100 TAH an alternative to conventional ASS preparations?].
    Maywald U; Schindler C
    Dtsch Med Wochenschr; 2005 Apr; 130(16):1026-7. PubMed ID: 15830316
    [No Abstract]   [Full Text] [Related]  

  • 16. [Opinion on the drug treatment of peptic ulcer].
    Tarpila S
    Duodecim; 1991; 107(22):1906-7. PubMed ID: 1365972
    [No Abstract]   [Full Text] [Related]  

  • 17. Omeprazole in acute and long-term treatment of Asian patients with peptic ulcer refractory to H2-antagonists.
    Chelvam P; Wong EC
    J Gastroenterol Hepatol; 1989; 4 Suppl 2():75-81. PubMed ID: 2577478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endoscopic changes in the stomach and duodenal mucosa caused by microdose acetylsalicylic acid therapy and their prevention--editorial].
    Ehrmann J; Procházka V; Konecný M; Spacek M; Urbánek K
    Vnitr Lek; 2007 Oct; 53(10):1024-8. PubMed ID: 18072422
    [No Abstract]   [Full Text] [Related]  

  • 19. [Studies on the protective effect of lansoprazole on human gastric mucosa against low-dose acetylsalicylic acid. An endoscopic controlled double-blind study].
    Müller P; Fuchs W; Simon B
    Arzneimittelforschung; 1997 Jun; 47(6):758-60. PubMed ID: 9281302
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of acid suppressants in prophylaxis of NSAID damage.
    Chan FK; Sung JJ
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):433-45. PubMed ID: 11403537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.